SA
Shilanski & Associates Portfolio holdings
AUM
$376M
1-Year Est. Return
19.08%
1 Year Est. Return
+19.08%
AUM
$376M
AUM Growth
+$26.3M
(+7.5%)
Holding
137
Top Buys
| 1 | +$5.14M | |
| 2 | +$4.99M | |
| 3 | +$3.65M | |
| 4 |
Amphenol
APH
|
+$3.05M |
| 5 |
Newmont
NEM
|
+$2.33M |
Top Sells
| 1 | +$4.64M | |
| 2 | +$2.42M | |
| 3 | +$2.4M | |
| 4 |
Target
TGT
|
+$2.4M |
| 5 |
Evercore
EVR
|
+$2.31M |
Sector Composition
| 1 | Technology | 12.67% |
| 2 | Financials | 7.11% |
| 3 | Consumer Staples | 5.99% |
| 4 | Industrials | 5.5% |
| 5 | Utilities | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Galicia Financial Group
GGAL
$8.37B
| – | – |
-7,983
|
|
||
127
Jones Lang LaSalle
JLL
$16.6B
| – | – |
-7,372
|
|
||
128
Leidos
LDOS
$24.5B
| – | – |
-13,411
|
|
||
129
Louisiana-Pacific
LPX
$6.52B
| – | – |
-19,177
|
|
||
130
MakeMyTrip
MMYT
$7.18B
| – | – |
-2,042
|
|
||
131
Oneok
OKE
$46.6B
| – | – |
-15,975
|
|
||
132
RELX
RELX
$76.1B
| – | – |
-4,990
|
|
||
133
Molson Coors Class B
TAP
$9.96B
| – | – |
-40,654
|
|
||
134
Teva Pharmaceuticals
TEVA
$37.4B
| – | – |
-10,115
|
|
||
|
135
Target
TGT
$50.4B
| – | – |
-24,332
|
|
||
136
TSMC
TSM
$1.78T
| – | – |
-1,080
|
|
||
137
UBS Group
UBS
$148B
| – | – |
-8,790
|
|